Structures of the PI3Kα/KRas complex on lipid bilayers reveal molecular mechanisms of PI3Kα activation

Hayarpi Torosyan1, Michael D Paul1, Brigitte G Meyer2

  • 1Cardiovascular Research Institute, University of California, San Francisco, San Francisco, CA 94158, USA.

Molecular Cell
|June 25, 2026
PubMed

Insights

This study reveals the molecular mechanism of PI3Kα activation using cryo-electron microscopy. The findings uncover new therapeutic targets for PI3Kα-driven cancers by mapping its conformational changes.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Structural Biology

Background:

  • Phosphoinositide 3-kinase alpha (PI3Kα) is a key oncogene.
  • It converts PIP2 to PIP3 at the plasma membrane, crucial for cell signaling.
  • Dysregulation of PI3Kα is implicated in various cancers.

Purpose of the Study:

  • To elucidate the molecular mechanisms governing PI3Kα activation.
  • To visualize the conformational states of PI3Kα during its transition to an active signaling complex.
  • To identify potential therapeutic targets for PI3Kα-driven oncogenesis.

Main Methods:

  • Cryo-electron microscopy (cryo-EM) was employed to determine high-resolution structures.
  • PI3Kα/KRas complexes were reconstituted and studied within lipid nanodiscs.
  • Cellular assays were performed to validate findings in a biological context.

Main Results:

  • Structures revealed a spectrum of PI3Kα conformations, illustrating the release of inhibitory domains.
  • PIP2 binding induced significant restructuring of active site regulatory elements.
  • An activating phosphopeptide promoted PI3Kα/KRas complex dimerization via a novel interface.
  • Dimeric PI3Kα was shown to amplify Akt signaling in response to growth factors in cells.

Conclusions:

  • The study provides a comprehensive map of PI3Kα conformational dynamics during activation.
  • Novel interfaces involved in PI3Kα activation and dimerization were identified.
  • These findings offer new avenues for developing targeted therapies against PI3Kα-.

Related Concept Videos

PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
Phosphoinositides and PIPs01:42

Phosphoinositides and PIPs

Phosphoinositides are a group of phospholipids containing a glycerol backbone with two fatty acid chains and a phosphate attached to a myoinositol sugar ring. The inositol head group extends into the cytoplasm, where it is modified by adding phosphate groups to form phosphatidylinositol phosphates or PIPs.
Different phosphoinositides are synthesized and recruited on the cytosolic face of the plasma membrane. The localization of specific phosphoinositides concentrated in separate membrane...
IP3/DAG Signaling Pathway01:11

IP3/DAG Signaling Pathway

Membrane lipids such as phosphatidylinositol (PI) are precursors for several membrane-bound and soluble second messengers. Specific kinases phosphorylate PI and produce phosphorylated inositol phospholipids. One such inositol phospholipids are the  phosphatidylinositol-4,5 bisphosphate [PI(4,5)P2], present in the inner half of the lipid bilayer. Upon ligand binding, GPCR stimulates Gq proteins to turn on phospholipase Cꞵ. Activated phospholipase Cꞵ cleaves PI(4,5)P2 and produces two-second...
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
Amplifying Signals via Second Messengers01:15

Amplifying Signals via Second Messengers

Many receptor binding ligands are hydrophilic; they do not cross the cell membrane but bind to cell-surface receptors. Thus, their message must be relayed by second messengers present in the cell cytoplasm. There are several second messenger pathways, each with its own way of relaying information. For example, the G protein-coupled receptors can activate both phosphoinositol and cyclic AMP (cAMP) second messenger pathways. The phosphoinositol pathway is active when the receptor induces...
Lipids as Anchors01:32

Lipids as Anchors

In the plasma membrane, the lipids forming the bilayer can also act as an anchor to tether proteins to the membrane. The three main types of lipid anchors found in eukaryotes are – prenyl groups, fatty acyl groups, and glycosylphosphatidylinositol or GPI groups. Prenyl and fatty acyl groups act as anchors on the cytosolic surface of the membrane, whereas GPI anchors proteins on the extracellular side.
The carboxy-terminal of most of the prenylated proteins, such as Ras proteins, contains the...